Breaking News

You are here » Indian-Commodity  :  Corporate  :  Strides Shasun reports over one fold jump in Q1 consolidated net profit

17-Aug2016

Strides Shasun reports over one fold jump in Q1 consolidated net profit

Strides Shasun has reported results for first quarter ended June 30, 2016.

The company has registered 87.32% growth in its net profit at Rs 27.18 crore for the quarter as compared to Rs 14.51 crore for the same quarter in the previous year. Total Income of the company increased by 41.32% to Rs 549.47 crore for quarter under review from Rs 525.01 crore for the quarter ended June 30, 2015.

On the consolidated basis, the company has reported over one fold jump in its net profit after taxes, minority interest and share of profit of associates at Rs 26.04 crore for the quarter ended June 30, 2016 as compared to Rs 10.62 crore for the same quarter in the previous year. However, total Income of the company increased by 41.32% to Rs 907.66 crore for quarter under review from Rs 642.26 crore for the quarter ended June 30, 2015.



Related News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......

Top News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......